Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Dow
US Department of Justice
Medtronic
Federal Trade Commission
Fuji
Johnson and Johnson
Chubb

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Teplizumab

« Back to Dashboard

US Patents for Teplizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Teplizumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Teplizumab ➤ Sign Up Compositions and methods of using proislet peptides and analogs thereof Cure DM Group Holdings, LLC (Wynnewood, PA) ➤ Sign Up
Teplizumab ➤ Sign Up Antibodies with enhanced or suppressed effector function Zymeworks Inc. (Vancouver, British Columbia, CA) ➤ Sign Up
Teplizumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Teplizumab ➤ Sign Up Stable heterodimeric antibody design with mutations in the Fc domain Zymeworks Inc. (Vancouver, CA) ➤ Sign Up
Teplizumab ➤ Sign Up Trispecific binding proteins and methods of use HARPOON THERAPEUTICS, INC. (Brisbane, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Teplizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Teplizumab Australia 2008292913 2027-08-30 ➤ Sign Up
Teplizumab Brazil PI0815308 2027-08-30 ➤ Sign Up
Teplizumab Canada 2698100 2027-08-30 ➤ Sign Up
Teplizumab China 101896499 2027-08-30 ➤ Sign Up
Teplizumab Colombia 6270235 2027-08-30 ➤ Sign Up
Teplizumab Cyprus 1116169 2027-08-30 ➤ Sign Up
Teplizumab Denmark 2193142 2027-08-30 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
US Department of Justice
McKesson
Colorcon
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.